Nicole H. Jennings - 13 Mar 2023 Form 4 Insider Report for DENBURY INC

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Mar 2023, 20:05:54 UTC
Prior SEC filing
09 Mar 2023
Next SEC filing
06 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robbie Hudson, attorney-in-fact for Ms. Jennings

Key filing fact

Nicole H. Jennings filed Form 4 for DENBURY INC on 15 Mar 2023.

Key facts

  • This page summarizes Nicole H. Jennings's Form 4 filing for DENBURY INC.
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Mar 2023, 20:05.

Change

  • Previous filing in this sequence was filed on 09 Mar 2023.
  • Current net transaction value: -$53,358.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DEN transaction

Common Stock

Sale

Transaction value
$48,730
Shares
-618
Change %
-1%
Price
$78.85
Shares after
60,443
Date
13 Mar 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DEN transaction Derivative

Series B Warrants (Right to Buy)

Sale

Transaction value
$4,628
Shares
-103
Change %
-100%
Price
$44.93
Shares after
0
Date
13 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
103
Exercise price
$35.41
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.84 to $78.875, inclusive. The reporting person undertakes to provide Denbury Inc., any security holder of Denbury Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F2

Theses Series B Warrants were sold in two lots, each at the price of $44.93. The reporting person undertakes to provide Denbury Inc., any security holder of Denbury Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the sale of the Series B Warrants.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .